BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7689294)

  • 1. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
    Adami F; Semenzato G; Menestrina F; Chilosi M
    Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
    Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
    Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease.
    Sundeen JT; Longo DL; Jaffe ES
    Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
    Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
    Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
    Brohée D; Cauchie P; Nève P
    Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
    Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
    Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate lymphocytic lymphoma massively involving the gastrointestinal tract.
    Tsutsumi Y; Osamura RY; Makuuchi H
    Pathol Int; 1996 May; 46(5):380-3. PubMed ID: 8809886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD5+ leukemic lymphoma with monocytoid features: an unusual B-cell lymphoma mimicking hairy-cell leukemia.
    Adami F; Chilosi M; Lestani M; Scarpa A; Zambello R; Pomponi F; Semenzato G; Menestrina F
    Acta Haematol; 1993; 89(2):94-9. PubMed ID: 7684880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia.
    Oka K; Mori N; Yatabe Y
    Acta Haematol; 1993; 90(2):84-9. PubMed ID: 8285023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders.
    Daenen S; van Voorst Vader PC; Blom N; Pietens J; Hollema H; Smit JW
    Br J Haematol; 1993 Oct; 85(2):307-12. PubMed ID: 7506566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD43 expression in B cell lymphoma.
    Treasure J; Lane A; Jones DB; Wright DH
    J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
    Faguet GB; Marti GE; Agee JF; Bertin P
    Ann N Y Acad Sci; 1992 May; 651():470-3. PubMed ID: 1376063
    [No Abstract]   [Full Text] [Related]  

  • 16. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue.
    Ortiz-Hidalgo C; Wright DH
    Histopathology; 1992 Dec; 21(6):555-61. PubMed ID: 1468755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5+, CD11C+, trap-positive chronic lymphocytic leukemia/prolymphocytic leukemia.
    Prince HM; Bashford J; van der Weyden MB
    Blood; 1992 Aug; 80(4):1095-6. PubMed ID: 1379851
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
    Paglieroni T; Caggiano V; MacKenzie MR
    Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigen density in B-cell chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Poncelet P
    Am J Clin Pathol; 1995 Mar; 103(3):375. PubMed ID: 7872264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.